Figure 3.

Prognostic value of the 6-snoRNAs signature is independent of conventional clinical factors. The riskscore and clinicopathological characteristics using (A) univariate cox analysis, (B) multivariate cox regression analyses. (C) Nomograms combining 6-snoRNAs signature and pathological features to predict 1-, 2-, 3-, 4-, and 5-years survival probability of patients with HCC. (D) Correction of the characteristic curve based on riskscore and pathological characteristic. HCC = hepatocellular carcinoma, snoRNAs = small nuclear RNAs.